261 related articles for article (PubMed ID: 23834512)
1. Leishmania major inhibits IL-12 in macrophages by signalling through CR3 (CD11b/CD18) and down-regulation of ETS-mediated transcription.
Ricardo-Carter C; Favila M; Polando RE; Cotton RN; Bogard Horner K; Condon D; Ballhorn W; Whitcomb JP; Yadav M; Geister RL; Schorey JS; McDowell MA
Parasite Immunol; 2013 Dec; 35(12):409-20. PubMed ID: 23834512
[TBL] [Abstract][Full Text] [Related]
2. Adenylate cycalse toxin of Bordetella pertussis inhibits TLR-induced IRF-1 and IRF-8 activation and IL-12 production and enhances IL-10 through MAPK activation in dendritic cells.
Hickey FB; Brereton CF; Mills KH
J Leukoc Biol; 2008 Jul; 84(1):234-43. PubMed ID: 18401006
[TBL] [Abstract][Full Text] [Related]
3. Leishmania major infection activates NF-kappaB and interferon regulatory factors 1 and 8 in human dendritic cells.
Jayakumar A; Donovan MJ; Tripathi V; Ramalho-Ortigao M; McDowell MA
Infect Immun; 2008 May; 76(5):2138-48. PubMed ID: 18316378
[TBL] [Abstract][Full Text] [Related]
4. Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of
Schleicher U; Liese J; Justies N; Mischke T; Haeberlein S; Sebald H; Kalinke U; Weiss S; Bogdan C
Front Immunol; 2018; 9():79. PubMed ID: 29459858
[TBL] [Abstract][Full Text] [Related]
5. Skin-derived macrophages from Leishmania major-susceptible mice exhibit interleukin-12- and interferon-gamma-independent nitric oxide production and parasite killing after treatment with immunostimulatory DNA.
von Stebut E; Belkaid Y; Nguyen B; Wilson M; Sacks DL; Udey MC
J Invest Dermatol; 2002 Sep; 119(3):621-8. PubMed ID: 12230504
[TBL] [Abstract][Full Text] [Related]
6. CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression.
Perera PY; Mayadas TN; Takeuchi O; Akira S; Zaks-Zilberman M; Goyert SM; Vogel SN
J Immunol; 2001 Jan; 166(1):574-81. PubMed ID: 11123339
[TBL] [Abstract][Full Text] [Related]
7. The role of IL-10 in promoting disease progression in leishmaniasis.
Kane MM; Mosser DM
J Immunol; 2001 Jan; 166(2):1141-7. PubMed ID: 11145695
[TBL] [Abstract][Full Text] [Related]
8. Phagocytosis of Leishmania mexicana amastigotes by macrophages leads to a sustained suppression of IL-12 production.
Weinheber N; Wolfram M; Harbecke D; Aebischer T
Eur J Immunol; 1998 Aug; 28(8):2467-77. PubMed ID: 9710224
[TBL] [Abstract][Full Text] [Related]
9. The role of mannose receptor during experimental leishmaniasis.
Akilov OE; Kasuboski RE; Carter CR; McDowell MA
J Leukoc Biol; 2007 May; 81(5):1188-96. PubMed ID: 17261547
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of dendritic cell signaling pathways by Leishmania amazonensis amastigotes.
Xin L; Li K; Soong L
Mol Immunol; 2008 Jul; 45(12):3371-82. PubMed ID: 18538399
[TBL] [Abstract][Full Text] [Related]
11. In experimental leishmaniasis deficiency of CD18 results in parasite dissemination associated with altered macrophage functions and incomplete Th1 cell response.
Schönlau F; Scharffetter-Kochanek K; Grabbe S; Pietz B; Sorg C; Sunderkötter C
Eur J Immunol; 2000 Sep; 30(9):2729-40. PubMed ID: 11009109
[TBL] [Abstract][Full Text] [Related]
12. Complement receptor 3 deficiency influences lesion progression during Leishmania major infection in BALB/c mice.
Carter CR; Whitcomb JP; Campbell JA; Mukbel RM; McDowell MA
Infect Immun; 2009 Dec; 77(12):5668-75. PubMed ID: 19797068
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 4 promotes control of Leishmania infantum infection through inducement of leishmanicidal activity in host macrophages: role of mitogen activated kinases.
Agallou M; Dotsika E; Frydas S; Karagouni E
J Biol Regul Homeost Agents; 2014; 28(1):41-52. PubMed ID: 24750790
[TBL] [Abstract][Full Text] [Related]
14. IRF4 in dendritic cells inhibits IL-12 production and controls Th1 immune responses against Leishmania major.
Akbari M; Honma K; Kimura D; Miyakoda M; Kimura K; Matsuyama T; Yui K
J Immunol; 2014 Mar; 192(5):2271-9. PubMed ID: 24489086
[TBL] [Abstract][Full Text] [Related]
15. Deletion of IL-4 receptor alpha on dendritic cells renders BALB/c mice hypersusceptible to Leishmania major infection.
Hurdayal R; Nieuwenhuizen NE; Revaz-Breton M; Smith L; Hoving JC; Parihar SP; Reizis B; Brombacher F
PLoS Pathog; 2013 Oct; 9(10):e1003699. PubMed ID: 24204259
[TBL] [Abstract][Full Text] [Related]
16. Pegylated bisacycloxypropylcysteine, a diacylated lipopeptide ligand of TLR6, plays a host-protective role against experimental Leishmania major infection.
Pandey SP; Chandel HS; Srivastava S; Selvaraj S; Jha MK; Shukla D; Ebensen T; Guzman CA; Saha B
J Immunol; 2014 Oct; 193(7):3632-43. PubMed ID: 25194056
[TBL] [Abstract][Full Text] [Related]
17. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI
Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349
[TBL] [Abstract][Full Text] [Related]
18. CD40 signaling is impaired in L. major-infected macrophages and is rescued by a p38MAPK activator establishing a host-protective memory T cell response.
Awasthi A; Mathur R; Khan A; Joshi BN; Jain N; Sawant S; Boppana R; Mitra D; Saha B
J Exp Med; 2003 Apr; 197(8):1037-43. PubMed ID: 12695487
[TBL] [Abstract][Full Text] [Related]
19. NF-kappa B1 is required for optimal CD4+ Th1 cell development and resistance to Leishmania major.
Artis D; Speirs K; Joyce K; Goldschmidt M; Caamaño J; Hunter CA; Scott P
J Immunol; 2003 Feb; 170(4):1995-2003. PubMed ID: 12574369
[TBL] [Abstract][Full Text] [Related]
20. Regulation of macrophage IL-12 synthesis by Leishmania phosphoglycans.
Piedrafita D; Proudfoot L; Nikolaev AV; Xu D; Sands W; Feng GJ; Thomas E; Brewer J; Ferguson MA; Alexander J; Liew FY
Eur J Immunol; 1999 Jan; 29(1):235-44. PubMed ID: 9933105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
